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A B S T R A C T
Animal infection models to study Mycobacterium avium subsp. paratuberculosis (MAP) infection are useful for
evaluating the efficacy of vaccines and other therapeutics for the prevention or treatment of infection. The goal
of the present study was to compare smaller ruminants, sheep and goats, with calves as infection models.
Neonatal sheep, goats, and calves (n = 4) received 109 cfu of a cattle isolate of MAP in milk replacer on days 0, 3
and 6 in a 12-month study and sampled monthly thereafter. Results demonstrated a robust antigen-specific IFN-γ
response at 90 days post-inoculation for sheep and goats, with lower responses noted for calves. By 360 days,
IFN-γ responses were 50 and 82% higher for calves than for goats and sheep, respectively. Although MAP-
specific antibody responses were first observed in sheep at 90 days, calves had higher antibody responses
throughout the remainder of the study. Following pass-through shedding on day 7, fecal shedding was fairly
negligible across treatments but remained higher for calves throughout the study. Colonization of tissues was
variable within treatment group and was higher for calves and sheep for the majority of tissues. Upon antigen
stimulation of PBMCs, higher populations of CD4 + T cells cells and lower populations of γδ TCR+ and NK cells
were observed for goats and calves compared to sheep. Relative gene expression of IL-4, IL-12, and IL-17 in
PBMCs was higher in goats, corresponding to lower tissue colonization with MAP. These data suggest that
ruminant species are fairly comparable as infection models for MAP, but discrete differences in host responses to
MAP infection exist between species.
1. Introduction
Animal infection models are useful for evaluating the efficacy of
vaccines and other therapeutics for the prevention or treatment of in-
fection. Infection models for Mycobacterium avium subsp. para-
tuberculosis (MAP) have been widely studied but to date there is no
infection model that closely mimics natural infection. A comprehensive
review of experimental challenge models for paratuberculosis was
performed by an international committee of researchers, with sub-
sequent publication of a set of host-specific standards for optimal in-
fection (Hines et al., 2007a). Although rodent models may be useful for
certain applications to study Johne’s disease, it is clear that one must
adhere to a ruminant model to capture the true dynamic of host im-
munity to infection. Johne’s disease is present in many ruminant species
worldwide but in the US prevalence of disease is much higher in dairy
cattle, with over 90% of US dairy herds reporting some level of infec-
tion (Lombard et al., 2013). With this in mind, we have performed
studies to evaluate ruminant species such as bison, white-tailed deer,
and beef calves as infection models, but have focused more extensively
on the application of the dairy calf model. Several studies were con-
ducted to identify the optimal route of infection including oral, oral
gavage, intraperitoneal, intratonsilar, and direct instillation into the
ileum through cannulation (Stabel et al., 2003; Waters et al., 2003;
Palmer et al., 2007; Stabel et al., 2009; Allen et al., 2012). In addition,
the source of the bacterium for the inoculum in the experimental in-
fection is a critical factor as recently demonstrated by comparing ex-
perimental inoculums of MAP from a low passage laboratory strain (K-
10) and a clinical isolate from ileal mucosal scrapings (Stabel et al.,
2009). Calves inoculated with the freshly isolated clinical strain had
more colonization in their tissues and more tissues were affected. The
continuous passage of a laboratory strain of MAP may impact its level of
virulence as protein expression is significantly impacted in a laboratory-
adapted strain compared to a clinical isolate (Radosevich et al., 2007).
However, calves are more expensive as infection models due to
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increased feed costs and housing costs if maintained in BSL-2 contain-
ment. They also do not progress to clinical disease within limited in-
fection periods. Smaller ruminants such as goats and sheep may be
more preferable as infection models, requiring less space and feed, and
demonstrating clinical signs within a shorter time span. The smaller
ruminant models for MAP infection have been extensively studied by
researchers in countries in which livestock such as goats and sheep
constitute key meat and dairy animals (Juste et al., 1994; Reddacliff
and Whittington, 2003; Munjal et al., 2005; Stewart et al., 2004;
Stewart et al., 2006; Kohler et al., 2015). However, to our knowledge
only one published study has performed a concurrent comparative
analysis of dairy calves, sheep and goats as infection models (Stewart
et al., 2007). Within the study, they also examined effects of inoculating
with sheep and bovine MAP strains and found that overall neither strain
was effective in sheep and calves, but goats were more susceptible to
MAP infection overall, regardless of strain.
The present study was conducted to compare lambs, goats, and
calves as infection models for MAP upon inoculation with a bovine
strain obtained from cows with clinical disease. In addition to evalua-
tion of tissue colonization and histopathology as an outcome of infec-
tion, comprehensive measures of host immunity to infection were
conducted. Assessment of broad host immune responses in the 3 species
after concomitant infection with the same MAP strain has not been
presented in the literature. It was our goal to determine if infection of
smaller ruminants (neonatal lambs and kids) would closely align with
infection of neonatal calves and if either lambs or goats would be an
appropriate model to supplant calves for testing of diagnostics, ther-
apeutics, and vaccines.
2. Materials and methods
2.1. Animals
Neonatal dairy calves were obtained from a local herd in Iowa and
neonatal goats and lambs were obtained on-site at the National Animal
Disease Center, all at less than one week of age. Preliminary screening
was performed to confirm negative status of dams prior to acceptance of
neonates. Animals were housed in a biosafety level-2 containment fa-
cility, with separate rooms for goats, lambs and calves throughout the
study. An acclimation period of one week was allowed prior to initia-
tion of the study. Standard commercial milk replacer (Land O’Lakes,
Shoreview, MN) was fed to goats, lambs, and calves twice per day at 10
hr intervals during the acclimation and experimental infection periods.
After the challenge period, animals were weaned onto calf starter (Kent
Feeds, Muscatine, IA) and then gradually switched over to a mixed
pelleted ration for the remainder of the study. Blood and fecal samples
were collected on two days prior to initiation of the study, followed by
sampling on days 7, 14, 28 and monthly thereafter for 12 months. All
animals were housed in an approved biosafety level-2 facility at the
National Animal Disease Center (NADC, Ames, IA). All animal related
procedures were approved by the Institutional Animal Care and Use
Committee prior to commencement of the study (IACUC, NADC).
2.2. Experimental infection of goats, lambs, and calves
Briefly, 4 Holstein dairy cows in clinical stage of disease were
purchased from the same outside vendor to serve as donors to provide
ileal mucosal scrapings to inoculate the goats, lambs, and calves.
Serologic tests were used to characterize clinical infection status ante-
mortem. Serum was harvested from whole blood and assayed for the
presence of MAP antibodies by commercial ELISA (Herdchek, IDEXX,
Westbrook, ME) and antigen-specific bovine IFN-γ was measured in
plasma using the Bovigam test kit (Prionics, La Vista, NE) as described
by the manufacturer. Donor cows averaged an ELISA antibody titer of
2.73 S/P ratio, IFN-γ responses of X (Abs450 MPS-NS) and fecal shed-
ding of 6305 cfu MAP/g of feces. One day prior to experimental
challenge of lambs, goats, and calves, the 4 donor cows were ne-
cropsied. At necropsy, the ileum sections and distal portions of the je-
junum were removed from the 4 donor cows and immediately rinsed
with 1X PBS. Sections of intestine were split longitudinal and the mu-
cosa was scraped using sterile glass slides. Aliquots of the mucosa (20 g)
were dispensed into 50-ml sterile conical tubes and prepped for im-
mediate use. The sample volume was brought up to 30 ml with PBS
containing penicillin (200,000 IU/liter) and chloramphenicol (200 mg/
liter), then incubated for 30 min at room temperature. After incubation,
mucosal samples were homogenized (Ultra-Turrax T25; IKA,
Wilmington,NC), brought up to a final volume of 40 ml, and added to
milk replacer at the morning feeding on days 0, 3, and 6 of the study.
Mucosal samples were stored at 4 °C until used to inoculate lambs,
goats, and calves. All procedures performed on the animals were ap-
proved by the Institutional Animal Care and Use Committee of the
National Animal Disease Center (NADC), Ames, IA. The number of vi-
able MAP in the inoculum preparation was verified by performing serial
10-fold dilutions of the stocks in PBS, followed by plating onto
Herrold’s egg yolk medium (HEYM; BD) in duplicate and culturing for
12 weeks at 39 °C. Total colony counts were performed for each dilu-
tion, and the average count extrapolated to an oral dose of 1.5 × 108
cfu viable MAP per inoculation per animal.
2.3. Tissue collection
Lambs, goats and calves were euthanized at 12 months post-infec-
tion for collection of ileum, ileo-cecal valve, regions of jejunum, duo-
denum, and lymph nodes of each region. Tissues were rinsed with 0.15
M PBS and cut into multiple cross-sections. One cross-section from each
tissue was fixed in 10% Zn-formalin for histopathology (CB Formalin,
Anatech, Ltd., Battle Creek, MI). Tissues fixed in formalin were cut into
cross-sections, embedded in paraffin, cut at 4-6 μm, and stained with H
&E and Ziehl-Neelen (ZN) for visualizing acid-fast bacteria. Each sec-
tion was evaluated using a rising scale from 0-5 for extent of granulo-
matous inflammation and acid-fast MAP bacilli. Scores were as follows:
0; granulomas/acid fast bacteria were not detected, 1; rare granulomas/
acid fast bacteria were present in a section, 2; a granuloma with acid
fast bacteria was typically present in each field, up to a score of 5;
granulomas and acid-fast bacteria were diffusely present and replaced
most of the normal architecture.
Additional sections of tissues were stored at −80 °C for culture of
MAP. Briefly, tissue Sections (2 g) were homogenized in 0.9% hex-
adecylpyradinium chloride solution with a gentleMACSTM Octo Dis-
sociator, using M tubes (Miltenyi Biotec, San Diego, CA). Following
overnight incubation, homogenates were pelleted by centrifugation at
900 x g for 30 min and re-suspended in an antibiotic cocktail containing
100 μg/mL nalidixic acid, 100 μg/mL vancomycin, and 50 μg/mL
amphotericin B (Sigma). Samples were incubated overnight and then
inoculated onto 4 slants of HEYM. Slants were incubated at 39 °C for at
least 12 weeks and colony counts of viable MAP were recorded and
averaged for the four slants.
2.4. Cell culture
Peripheral blood mononuclear cells (PBMCs) were isolated from the
buffy coat fractions of blood. PBMCs were resuspended in complete
media [RPMI-1640 (Gibco, Grand Island, N.Y.) with 10% fetal calf
serum (Atlanta Biologics, Atlanta, Ga.), 100 U of penicillin G sodium
(Gibco) per mL, 100 μg of streptomycin sulfate (Gibco) per mL, 0.25 μg
of amphotericin B (Gibco) per mL, and 2 mM l-glutamine (Gibco)]. Cells
were cultured at 2.0 × 106/mL in replicate 48-well flat-bottomed plates
(Corning Incorporated, Corning, NY) for 1, 3 or 6 days at 39 °C in 5%
CO2 in a humidified atmosphere. Duplicate wells were set up for each
animal for the following in vitro treatments: medium only (non-
stimulated, NS), concanavalin A (ConA; 10 μg/ml; Sigma), pokeweed
mitogen (PWM; 10 μg/ml; Sigma) and a whole-cell sonicate preparation
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of MAP (MPS; 10 μg/ml). The two mitogens, ConA and PWM, were
included as positive controls for assays following cell culture to make
certain that PBMCs were responsive. For cytokine analyses, one set of
plates were removed at 1 and 3 days and centrifuged at 400 x g for 5
min. Supernatants were removed without disturbing the cells in culture,
and stored at −20 °C prior to cytokine measurement. A replicate set of
plates was incubated for either 3 days (NS, ConA, and PWM) or 6 days
(NS, MPS) and cells were harvested for flow cytometric analyses.
2.5. Cytokine analyses of cell culture supernatants
Bovine IL-10 was quantified as previously described (Stabel et al.,
2013) using anti-bovine IL-10 antibodies (MCA2110, MCA2111B; Ser-
otec, Raleigh, NC) and a bovine IL-10 standard (0.3125-20 ng/mL)
(Kingfisher Biotech, Saint Paul, MN). Similarly, bovine IL-12 in cell
culture supernatants was measured by ELISA using anti-bovine IL-12
antibodies (MCA1782EL, MCA2173B; Serotec), and a bovine IL-12
standard (55-1500 U/ml; Kingfisher Biotech, Inc.). Further cytokine
analyses of culture supernatant for IFN-γ, IL-1β, IL-2, IL-4, IL-6, and
tumor necrosis factor (TNF)-α concentration was performed using
Custom Bovine Arrays (Cira Custom Bovine 6-Plex Array Kit, Aushon
Biosystems, Billerica, MA) according to the manufacturer’s instructions.
Concentrations (pg/mL) of each cytokine were quantified in samples
using Searchlight array software (Aushon Biosystems) by referencing to
a standard curve for each cytokine. Measurement of bovine IL-17A
(Kingfisher Biotech, Inc.) was performed according to manufacturer’s
instructions.
2.6. Flow cytometric analyses
Briefly, cells in culture plates were gently resuspended and 50 μl of
cell suspension was added to wells of 96-well round bottom plates
(Corning Incorporated, Corning, NY) containing 50 μL of primary
monoclonal antibody to CD4, CD8, CD335 and γδ T cells; B cells and
CD14, as well as memory/activation markers CD25, CD26, CD28, and
CD45RO (Table 1). Cells were then incubated at 4 °C for 30 min. After
incubation, plates were centrifuged at 1250 rpm for 2 min at 4 °C and
the supernatant decanted. 100 μL of secondary antibody cocktail con-
sisting of fluorescein-conjugated anti-mouse IgM (Southern Biotech,
Birmingham, AL), R-phycoerythrin-conjugated goat F(ab)2 anti-mouse
IgG2a (Southern Biotech, Birmingham, AL), and peridinin-chlorophyll-
protein complex-conjugated rat anti-mouse IgG1 (Becton Dickinson, San
Jose, CA) diluted 1:312, 1:625, and 1:42 respectively, in PBS with 1%
fetal calf serum and 0.04% sodium azide was then added to designated
wells and the plate was centrifuged again at 1250 rpm for 2 min at 4 °C.
The cells were then suspended in 200 μL of BD FacsLyse (BD Bios-
ciences, San Jose, CA) for immediate flow cytometric analysis. Samples
were evaluated using 30,000 events per sample using a FACScan flow
cytometer (Cell Quest Software; Becton Dickinson). Mononuclear cells,
based on forward and side scatter characteristics, were analyzed for cell
surface marker expression (FlowJo, Tree Star, Inc., San Carlos, CA).
2.7. RNA extraction and reverse transcription
RNA was extracted from PBMCs after 24 hr of culture with in vitro
treatments (NS, MPS) as described above. Briefly, cells from duplicate
wells were harvested after centrifugation of plates at 1500 rpm for 5
min and lysed with 350 μl of buffer RLT (Qiagen, Valencia, CA). RNA
was isolated using an RNeasy Mini Kit (Qiagen) according to the
manufacturer's directions and eluted from the column with 40 μl of
RNase-free water (Ambion, Austin, TX). Total RNA (500 ng) was re-
verse transcribed using SuperScript III (Invitrogen, Carlsbad, CA) with
150 ng of random hexamers, 10 mM dNTPs and 40 units of RNaseOut
(Invitrogen), according to the manufacturer's directions. Samples were
heated to 65 °C for 5 min and then reverse transcribed at 50 °C for 60
min. The resulting cDNA were stored at −80 °C until used in real-time
PCR.
2.8. Cytokine gene expression
Real-time PCR was performed using custom Taqman Gene
Expression Assays for bovine IL-4, IL-10, IL-12, IL-17A, IL-18, IL-23,
IFN-γ, TGF-β, and iNOS (Life Technologies, Grand Island, NY) ac-
cording to the manufacturer's directions for relative quantitation.
Target sequences for aforementioned cytokines are presented in
Table 2. Briefly, 4 μl of cDNA template was added to a 20 μl reaction
mixture containing Taqman Universal PCR Master Mix and Gene Ex-
pression Assay working stock consisting of forward and reverse primers
and FAM-MGB probe. Eukaryotic 18S rRNA endogenous control (FAM-
MGB probe, non-prime limited; Invitrogen) was used as an internal
control to normalize RNA content between samples. The NS sample was
used as the calibrator. All reactions were performed in triplicate, and
data were analyzed with the 2−ΔΔCt method.
2.9. Statistical analyses
Data were analyzed using the PROC Mixed procedure of the
Statistical Analysis System (SAS Institute, Cary, NC). Values were re-
ported as least square means± the standard error of the mean. When
significant effects (P<0.05) due to infection or in vitro treatment were
observed, a means comparison was conducted using the Tukey-Kramer
post hoc test. Values were also used to conduct principal component
analysis (PCA) on correlations between animal species using the PROC
PrinComp procedure of SAS (SAS). Scattergram score plots of principal




Antigen MAb clone Isotype Working MAb
concentrationb
Specificity
CD4 GC50A1 IgM 14 T-helper cell
CD8 CACT80C IgG1 14 T-cytotoxic/
suppressor cell
N12 CACT61A IgM 14 γδ-cell receptor
B cell PIG45A IgG2b 7 Total B cell
CD25 LCTB2A IgG3 15 IL-2 receptor
CD26 CACT114A IgG2b 15 Activation marker
CD45RO GC42A1 IgG1 10 Memory/activation
marker
CD335 BAG40 IgG3 10 NK cell
a VMRD Inc. (Pullman, WA).
b Diluted in PBS with 1% fetal calf serum and 0.04% sodium azide; μg/ml.
Table 2
Real-time PCR Bovine Cytokine Gene Target Sequencea.











a Gene Expression Assay, Life Technologies (Grand Island, NY).
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3. Results
3.1. Infection status monitoring
An assessment of differences due to animal species on general ante-
mortem diagnostic tools was the first priority of the study and results
for whole blood IFN-g responses are shown in Fig. 1. Results to ConA
were demonstrated as early as day 0, prior to infection, in neonatal
calves (P<0.05) with negligible responses for lambs and goats
(Fig. 1A). Lambs and goats began to respond by day 90 of the study and
by day 180, ConA-mediated responses were similar in goats and calves.
In the latter days of the study responses began to wane for sheep and
goats but remained at high levels (P<0.01) for calves. This pattern
was repeated upon stimulation with PWM, with higher (P<0.001)
responses for calves throughout, although responses were more robust
for all animal species (Fig. 1B). Antigen-specific IFN-γ responses were
not observed until day 90 of the study and, interestingly, responses
were significantly (P<0.001) higher for lambs and goats compared to
calves (Fig. 1C). By day 180 responses were similar for all three species,
averaging Abs450nm3.72± 0.22. Responses to antigen were diminished
(P<0.05) in goats at day 270 but responses remained similar for lambs
and calves. Declines in antigen-specific IFN-γ were noted for all 3
species by day 360 but were significantly (P<0.001) higher for calves
compared to either lambs or goats (Abs450nm 2.18 vs 1.08 and 0.38,
respectively. Serum MAP-specific antibody responses were noted 90
days post-inoculation in lambs (P<0.01), with little to no responses
noted for goats and calves (Fig. 2). By day 180, calves had higher
(P<0.05) levels of serum antibody (S/P 1.24± 0.32) compared to
lambs and goats (S/P 0.67±0.27 and 0.78±0.11, respectively).
Serum antibody continued to increase for calves through day 360 of the
study (S/P 1.71± 0.38) but remained fairly static for lambs and goats.
3.2. Fecal and tissue culture results
Fecal shedding of MAP was significantly (P<0.001) higher for
goats on day 7 of the study (Fig. 3). This was consistent for all 4 animals
in this group, averaging greater than 44,000±1914 cfu/g feces. In
comparison, 4 of the lambs averaged shedding of 3503±2248 cfu/g
feces and only one calf shed MAP on day 7 (45,398 cfu/g). Throughout
the remainder of the study lambs and goats shed sporadically with one
or two animals per group shedding at any time point and at compara-
tively low levels. In contrast, calves shed more consistently with all 4
calves engaged throughout the remainder of the study but higher
(P<0.05) levels noted only on day 90 compared to lambs and goats.
Tissue colonization is a key criterion for assessment of an effective
infection model. We evaluated infection primarily in tissues of the small
intestine, the key target tissue for MAP (Fig. 4). Calves demonstrated
higher levels of MAP in the ileo-cecal valve and ileo-cecal valve LN
(P<0.05) compared to lambs and goats. However, calves and lambs
had similar levels of colonization of ileal and jejunal tissues and asso-
ciated lymph nodes and goats had significantly (P<0.01) fewer
numbers of viable MAP in these tissues (Fig. 4B). Although the duo-
denum is not normally considered a major target area within the small
intestine for MAP, colonization was significant (P<0.05) in this tissue
Fig. 1. Secretion of interferon-gamma (IFN-γ; Abs450) in whole blood assay
after stimulation for 24 h in vitro with Conconavalin A (A; ConA; 10 μg/ml);
pokeweed mitogen (B; PWM; 10 μg/ml) and a whole cell sonicate (C; MPS; 10
μg/ml) of Mycobacterium avium subsp. paratuberculosis in lambs, goats, and
calves over the course of 12-month infection. Data are expressed as
means± SEM; *P<0.05.
Fig. 2. Serum antibody responses (S/P ratio) to Mycobacterium avium subsp.
paratuberculosis in lambs, goats, and calves over the course of 12-month in-
fection. Results are expressed as sample to positive ratio (S/P). Data are ex-
pressed as means± SEM; *P<0.05.
Fig. 3. Fecal shedding (CFU/g) of Mycobacterium avium subsp. paratuberculosis
in lambs, goats, and calves over the course of 12-month infection. Data are
expressed as means± SEM; *P<0.05.
J.R. Stabel, et al. Veterinary Immunology and Immunopathology 225 (2020) 110060
4
for lambs, with a low level noted for goats and negligible amounts for
calves (Fig. 4C). Results for histopathologic comparison demonstrate
differences between species in AF and lesion scores (Table 3). Overall,
AF bacilli were observed in 16 tissues from 2 of the 4 calves, with scores
averaging 2 for the 2 positive calves. Additionally, 16 tissues were
positive for granulomatous lesions (3 of 4 calves). AF bacilli were found
in 5 tissues (3 of 4 lambs) and 3 tissues (1 of 4 goats) for lambs and
goats, respectively, with scores of 1, indicating few bacilli. Granulo-
matous lesions were observed in 9 tissues from each group.
3.3. Cell populations
Responses to mitogens, ConA and PWM, are not presented or dis-
cussed herein in any detail as they were included as positive controls to
assess the ability of cells to respond appropriately in a number of as-
says. For a good number of the assays, the responses for mitogens and
antigen paralleled each other within an animal species. The premise of
the present study was to evaluate differences in host immunity to MAP
infection among the 3 species of ruminants, so we focused on antigen-
specific host immune responses. On day 360 of the study, when asses-
sing cell populations within total PBMCs after stimulation with MPS,
Fig. 4. Culture results (CFU/g) for Mycobacterium avium subsp. paratuberculosis in tissues: ileo-cecal valve (ICV) and ICV lymph node (LN) (A); ileum, jejunum and
associated lymph nodes (B); duodenum (duod) and associated lymph node (C) in lambs, goats, and calves after 12 months of infection. Data are expressed as
means± SEM; *P<0.05.
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percentages of CD4 + T cells were higher (P<0.01) for goats and
calves, whereas CD8+ T cell percentages were higher (P<0.05) for
lambs and goats (Fig. 5). It was also interesting to note that lambs had
higher (P<0.05) numbers of γδ TCR + T cells and NK cells compared
to goats and calves. Lastly, the number of B cells in the total PMBC
population was higher (P<0.05) for goats and calves. The upregula-
tion of activation markers CD26 and CD28 were used to assess func-
tional activity of the T cell subpopulations (Fig. 6). A stepwise decrease
in CD26 expression was observed from lambs to goats to calves on CD8
and γδ TCR + T cells (Fig. 6A). The expression of CD28 differed ac-
cording to cell type, with greater expression (P<0. 05) on CD4 + T
cells but lower (P<0.05) expression observed on γδ TCR + and NK
cells for lambs as compared to calves. In each incidence, expression of
CD26 and CD28 on T cell subpopulations was intermediate for goats
between lambs and calves.
3.4. Cytokine secretion and gene expression
Cytokine secretion provided a further assessment of host immunity
to MAP infection and is shown after stimulation of PBMCs with MPS
antigen for either 24 or 72 hours (Fig. 7). Secretion of IFN-γ was higher
(P<0.05) for calves compared to lambs and goats on day 360. IL-1
secretion was higher (P<0.05) for calves as well, but only compared to
goats (Fig. 7A). This is in contrast to the secretion of pro-inflammatory
cytokine, IL-17A, which was significantly (P<0.05) lower for calves
than for goats in this study (Fig. 7B). Additionally, IL-2 (P<0.05) and
IL-12 secretion (p=0.32) was lower for calves compared to both lambs
and goats (Fig. 7A). Interestingly, secretion of MPS-stimulated IL-10
was higher (P<0.05) for calves than for lambs with intermediate le-
vels noted for goats (Fig. 7B).
Relative expression of cytokine genes provided some additional
evidence of species differences in host responses to MAP infection
(Fig. 8). Interestingly, stimulation of PBMCs with MPS resulted in up-
regulation of cytokine genes more frequently in goats than in either
lambs or calves. Cytokines typically secreted by antigen-presenting cells
such as IL-12 (P<0.01) and IL-18 were elevated in goats compared to
lambs and calves (Fig. 8A). Th1-mediated cytokines did not present a
clear discrimination between species other than for elevated IFN-γ gene
expression noted for goats and calves (Fig. 8A). Expression of IL-17 was
higher (P<0.05) for goats compared to lambs and calves. Additionally,
IL-4 gene expression was upregulated (P<0.05) in goats compared to
lambs and calves (Fig. 8B). A stair step increase, although not sig-
nificant, in IL-10 gene expression was observed from lambs to goats to
calves (Fig. 8B) that corresponded well with IL-10 secretion.
4. Discussion
Animal models are critical to the study of infectious pathogens and
disease and can provide valuable information about the efficacy of
drugs, therapies, and preventatives such as vaccines. Paratuberculosis is
an inflammatory enteritis associated with domestic ruminants such as
cattle, sheep, and goats (Fecteau, 2018; Windsor, 2015), as well as
wildlife such as deer, elk, bison, antelope, and alpaca (Dukes et al.,
1992; Nebbia et al., 2000; Raizman et al., 2005; Sibley et al., 2007;
Fecteau et al., 2009; Murray et al., 2014; Forde et al., 2015). A wide
variety of nonruminant species can certainly become infected with MAP
but fail to develop characteristic pathologic lesions associated with the
disease (Beard et al., 2001). The optimization of an animal model for
the study of MAP infection is stymied by the complexity of this disease.
In nature, animals generally become infected as neonates, but this is
followed by an ill-defined period of asymptomatic infection. Disease
progression from a subclinical to a clinical state, however, is unlikely to
occur in cattle prior to 2 years of age. This age logically corresponds to
the advent of calving for the first time, along with the associated
stressors of lactation. An ideal animal model would mimic natural
disease by following a course from subclinical to clinical disease.
However, due to constraints in the lack of availability of long-term
housing for large animals, researchers often have to limit their studies
Table 3
Summary of histopathology for tissues obtained from lambs, goats, and calves
at necropsy 12 months post-infection.a
Treatment AF+Tissues AF Score Granuloma+Tissues
Lambs 5 1.0 9
Goats 3 2.0 9
Calves 16 2.0 16
a Tissues were stained for the presence of acid-fast (AF) bacilli using Ziehl-
Neelsen and granulomatous lesions were determined on tissues stained using H
&E. AF score ranged from 1 to 5 and was averaged across positive tissues within
each group.
Fig. 5. Lymphocyte populations of
CD4, CD8, γδ TCR, NK, and B cells,
within total PBMCs isolated from
lambs, goats, and calves after 12
months of infection. Cells were stimu-
lated in vitro for 6 days with a whole
cell sonicate (MPS) of Mycobacterium
avium subsp. paratuberculosis. Data are
expressed as means± SEM; *P<0.05,
**P<0.01.
J.R. Stabel, et al. Veterinary Immunology and Immunopathology 225 (2020) 110060
6
to short-term models.
Substituting a calf with a smaller ruminant such as a lamb or a goat
kid in an animal model would be helpful in allaying some of issues
associated with housing and care of the animals during a long-term
study. Lamb infection models for MAP have been established and there
are numerous reports available in the literature with study periods
ranging from 56 days to 54 months (Gilmour and Brotherston, 1962;
Stewart et al., 2004). Among these studies, a sheep isolate of MAP was
used as the source of inoculum for the majority of them, but there have
also been studies incorporating either a bovine isolate or a deer isolate
of MAP (Kluge et al., 1968; Merkal et al., 1968; Juste et al., 1994;
Burrells et al., 1998; Stewart et al., 2004). Less is known about para-
tuberculosis in goats and this is speculated to be due to a lesser im-
portance of this species in developed countries, as a livestock com-
modity compared to sheep and cattle (Windsor, 2015). Similar to sheep,
goats are susceptible to both the bovine (C) and sheep (S) strains of
MAP and share many similarities in how the disease is presented
(Stewart et al., 2006). Successful goat infection models have been de-
veloped, with the majority of them utilizing a clinical goat isolate and
an oral mode of inoculation and extending up to 54 months duration
(Hines et al., 2007b; Sigurdardottir et al., 1999; Storset et al., 2001;
Kohler et al., 2015). How closely the sheep and goat models for MAP
infection align to the calf model is not well understood.
To date, only one comparative study has been published evaluating
infectivity in sheep, goats and calves using the same bovine or ovine
isolates of MAP (Stewart et al., 2007). Upon termination of the long-
term study, goats had more evidence of clinical disease and were the
only species with positive tissue culture of MAP. Interestingly, there
was more evidence for clinical disease in goats challenged with the
bovine isolate compared to the ovine isolate, a finding that was cor-
roborated by an earlier study in red deer that the bovine isolate resulted
in greater infectivity and lesion scores compared to the ovine isolate
Fig. 6. Expression of CD26 (A) and CD28 (B) activation markers on lymphocyte populations of CD4, CD8, γδ TCR, and NK cells within total PBMCs isolated from
lambs, goats, and calves after 12 months of infection. Cells were stimulated in vitro for 6 days with a whole cell sonicate (MPS) of Mycobacterium avium subsp.
paratuberculosis. Data are expressed as means± SEM; *P<0.05.
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(Mackintosh et al., 2012). The higher infectivity in goats is inconsistent
with those obtained in the present study. Although only a bovine isolate
of MAP was used as the inoculum, tissue colonization was consistently
lower in goats in key target tissues such as the ileum and jejunum, with
results for calves and lambs aligning more closely with each other. Only
the ileo-cecal valve and its associated lymph node demonstrated a
comparable infectivity for lambs and goats although it was lower than
colonization noted for calves. Differences in infectivity between rumi-
nant species are difficult to explain but would seem subject to host
immune responses to infection since all other aspects of the study in-
cluding housing, feeding, and inoculum were the same.
Measures of host immunity in the present study were undertaken to
elucidate any differences that might be present between species upon
challenge with virulent MAP. There were multiple findings that shed
some light onto potential mechanisms that would result in greater in-
fectivity observed in calves and sheep. Temporal results for serum an-
tibody and whole blood IFN-γ responses would lead one to speculate
that lambs and goats aligned themselves with one another more closely
than to calves. Both lambs and goats had early antigen-specific
serologic responses, but calves caught up by 180 days and had greater
and more sustained responses throughout the remainder of the study.
Delving down deeper into host immune responses, several provocative
findings provide information to explain host differences to MAP infec-
tion. The secretion of IFN-γ, IL-2 and IL-10 by MPS-stimulated PBMCs
further demonstrated an alignment between lambs and goats that was
disparate to calves. It was interesting to note that calves had higher
antigen-specific secretion of IFN-γ and IL-1β, both pro-inflammatory
cytokines, but also had higher secretion of IL-10, a key regulatory cy-
tokine. However, the observation of higher IL-17A secretion for goats
compared to lambs and calves may be more noteworthy. Secretion of
IL-17A was further substantiated by higher gene expression for IL-17A,
and also for higher expression of IL-4, IFN-γ and IL-12. Upon exposure
to pathogens, activated macrophages and other antigen-presenting cells
initiate a cascade of events that can include polarization of naïve CD4 T
cells to Th17 T cells (Kaiko et al., 2008). Once macrophages are acti-
vated they can induce IFN-γ and IL-12, contributing to a protective role
against infection (Das and Khader, 2017). The higher IL-4 gene ex-
pression noted for goats would seem counterintuitive to the IL-17
Fig. 7. Secretion of cytokines (pg/ml): interferon-gamma (IFN-γ), interleukin-2 (IL-2), interleukin-1-beta (IL-1β), interleukin-12 (IL-12) (A), and interleukin-10 (IL-
10), and interleukin-4 (IL-17A) (B), by PBMCs isolated from lambs, goats, and calves after 12 months of infection. Cells were stimulated for 24 and 72 h in vitro with
a whole cell sonicate (MPS) of Mycobacterium avium subsp. paratuberculosis. Data are expressed as means± SEM; *P<0.05.
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paradigm but IL-17 can become resistant to IL-4 suppression during
chronic exposure to a pathogen (Cooney et al., 2011). So the question
would be whether a directed host immune response towards IL-17
would account for the lower level of infection noted in the goats in this
study.
The host response of sheep to MAP infection was variable for cy-
tokine gene expression, more often aligning with calves, but cytokine
secretion was somewhat in between that of calves and goats. One in-
teresting highlight for lambs was that RANTES expression was higher
than for calves and goats. Furthermore, lambs also had higher per-
centages of antigen-stimulated CD8+, γδ TCR + T cells and NK cells,
cell populations that are associated with RANTES expression (Cipriani
et al., 2000; Roda et al., 2006; Tikhonov et al., 2010). RANTES is a
product of both circulating lymphocytes and epithelial cells in the
mucosa and functions primarily in chemotaxis of lymphocytes to areas
of inflammation (Lillard et al., 2001). A role for NK cells in the initia-
tion of a specific immune response by facilitating T-cell recruitment has
also been demonstrated. Activated NK cells have been reported to se-
crete low amounts of several T cell–recruiting chemokines, including
RANTES. RANTES potentiates the secretion of cytokines such as IFN-γ,
IL-2, IL-5 and IL-6 and upregulates the expression of CD28 on CD4 + T
cells, an event that was observed for lambs in the present study. It is
suggested that the multi-faceted influence of RANTES on Th1 and Th2-
responses provides a link between the innate and adaptive immune
responses (Lillard et al., 2001). This would be a critical factor in con-
trolling MAP infection.
Another major difference demonstrated within the study between
species was the expression of activation markers, CD26 and CD28, on T
cell subpopulations. Higher CD26 expression was observed on CD8+
and γδ TCR + T cells for lambs, and higher CD28 was noted on CD4 +
T cells. In contrast, higher CD28 expression was noted on γδ TCR + T
cells and NK cells for calves. CD26, a dipeptidyl peptidase, is a cell
surface glycoprotein that acts as a co-stimulatory signal for T cell ac-
tivation, invoking cytokine and chemokine secretion (Gorrell et al.,
2001). We have previously observed upregulation of CD26 expression
on T cell populations in experimentally infected calves within 3 months
post-inoculation (Stabel and Robbe-Austerman, 2011)). Unlike CD26,
expression of TCR is not essential for CD28 activity to occur. Although
CD28 is another co-stimulatory molecule, it functions through inter-
actions with B7 ligands, CD80 and CD86 that are present on antigen-
presenting cells (Bour-Jordan and Blueston, 2002). The differences in
CD26 and CD28 expression noted were more dichotomous between
lambs and calves within the study. Although is it unclear the exact
premise for these differences perhaps the collaboration between innate
and adaptive immunity occurs through a different mechanism in these
two species.
Fig. 8. Relative gene expression (2-ddCt) for cytokines by PBMCs isolated from lambs, goats, and calves after 12 months of infection. Cells were stimulated for 24 h in
vitro with a whole cell sonicate (MPS) of Mycobacterium avium subsp. paratuberculosis. Data are expressed as means± SEM; *P<0.05, **P<0.01.
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Collectively, the 3 species of ruminants shared many characteristics
in host responses and infection pattern after challenge with MAP (Figs.
S1-8). Similarities were observed in the fecal shedding of MAP, as well
as tissue colonization (Figs. S2-4). Despite this, it was clear that calves
held a unique position in the degree of infectivity and robustness of
responses as noted for cytokine secretion (Fig. S5), cytokine gene ex-
pression (Fig. S6), and activated T cell populations (Fig. S8). Moreover,
PCA demonstrated that goats were moderate in their measured re-
sponses, either aligning with calves or lambs, or at times falling be-
tween calves and lambs.
Finally, the outcome of the infection model in calves yielded few
surprises. We have worked diligently on the proper model for use in our
laboratory to test and evaluate new vaccine candidates and therapeutics
with the idea that a positive readout from treatment would be indicated
by a reduction in tissue colonization. In the present study, the host
immune profile demonstrated by the calves fits the paradigm of a robust
infection, with strong antigen-specific IFN-γ and serum antibody re-
sponses. In addition, infection for 12 months resulted in the most
consistent and highest level of colonization in the key target tissues for
MAP infection, a critical component of a successful infection model.
Peripheral immune responses such as higher CD4+ and B cell popu-
lations, along with balanced expression of IFN-γ and IL-10 are also
indicators of a model that would traverse Th1 and Th2 immunity, akin
to natural infection in the field.
In summary, although sheep and goats share many similar proper-
ties as infection models to calves, overall calves proved to be a more
standardized model with demonstrable fecal shedding, tissue coloni-
zation and host immune responses upon long-term infection. It is cer-
tainly up to the researcher to define their needs and goals in order to
select the appropriate infection model. This may be impacted by
practical factors associated with housing and feeding of animals in long-
term studies as well as being driven by producer interest in the domi-
nant livestock species in the region.
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